Transmission X-ray microscopy-based three-dimensional XANES imaging.

Full-field transmission X-ray microscopy (TXM) in conjunction with X-ray absorption near edge structure (XANES) spectroscopy provides two-dimensional (2D) or three-dimensional (3D) morphological and chemical-specific information within samples at the tens of nanometer scale. This technique has a broad range of applications in materials sciences and battery research. Despite its extensive applicability, 2D XANES imaging is subject to the disadvantage of information overlap when the sample thickness is uneven.

Image registration for in situ X-ray nano-imaging of a composite battery cathode with deformation.

The structural and chemical evolution of battery electrodes at the nanoscale plays an important role in affecting the cell performance. Nano-resolution X-ray microscopy has been demonstrated as a powerful technique for characterizing the evolution of battery electrodes under operating conditions with sensitivity to their morphology, compositional distribution and redox heterogeneity. In real-world batteries, the electrode could deform upon battery operation, causing challenges for the image registration which is necessary for several experimental modalities, e.

Full-field hard X-ray nano-tomography at SSRF.

An in-house designed transmission X-ray microscopy (TXM) instrument has been developed and commissioned at beamline BL18B of the Shanghai Synchrotron Radiation Facility (SSRF). BL18B is a hard (5-14 keV) X-ray bending-magnet beamline recently built with sub-20 nm spatial resolution in TXM. There are two kinds of resolution mode: one based on using a high-resolution-based scintillator-lens-coupled camera, and the other on using a medium-resolution-based X-ray sCMOS camera.

p21-activated kinase 7 is an oncogene in human osteosarcoma.

p21-activated kinase 7 (PAK7), also named as PAK5, is a member of Rac/Cdc42-associated Ser/Thr protein kinases. It is overexpressed in some types of cancer such as colorectal and pancreatic cancers. However, the expression status and biological function of PAK7 in osteosarcoma are still ambiguous.